SECAUCUS, N.J., Dec. 21,
2023 /PRNewswire/ -- Quest Diagnostics Incorporated
(NYSE: DGX), the nation's leading provider of diagnostic
information services, announced that Jim
Davis, Chairman, CEO and President, and Sam Samad, Executive Vice President and Chief
Financial Officer, will speak on the company's strategy,
performance, and the latest market developments and trends during a
fireside chat at the 42nd Annual J.P. Morgan Healthcare
Conference in San Francisco on
Tuesday, January 9, 2024, at
6:45 p.m. Eastern Time.
The fireside chat and Q&A session will be webcast live
during the conference and will be available on the company's
investor relations page which can be accessed at
ir.QuestDiagnostics.com. In addition, the archived webcast will be
available within 24 hours after the conclusion of the live event
and will remain available until February 8,
2024.
About Quest Diagnostics
Quest Diagnostics empowers
people to take action to improve health outcomes. Derived from the
world's largest database of clinical lab results, our diagnostic
insights reveal new avenues to identify and treat disease, inspire
healthy behaviors and improve health care management. Quest
annually serves one in three adult Americans and half the
physicians and hospitals in the United
States, and our nearly 50,000 employees understand that, in
the right hands and with the right context, our diagnostic insights
can inspire actions that transform lives.
www.QuestDiagnostics.com.
View original content to download
multimedia:https://www.prnewswire.com/news-releases/quest-diagnostics-to-speak-at-the-42nd-annual-jp-morgan-healthcare-conference-302021216.html
SOURCE Quest Diagnostics